The role of angiogenesis in vulvar cancer, vulvar intraepithelial neoplasia, and vulvar lichen sclerosus as determined by microvessel density analysis

Gynecologic Oncology

Volumn 89, Issue 2, 2003, Pages 251-258

  Saravanamuthu, Jamna ^a   Reid, Wendy M N ^a   St George, David ^a   Crow, Julie C ^a   Rolfe, Kerstin J ^a   MacLean, Allan B ^a   Perrett, Christopher W ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Lichen sclerosus; Microvessel density; Squamous cell carcinoma; Von Willebrand factor; Vulva; Vulvar intraepithelial neoplasia

Indexed keywords

BIOTIN; HORSERADISH PEROXIDASE; PARAFFIN; STREPTAVIDIN;

ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; MALIGNANT NEOPLASTIC DISEASE; MICROVASCULATURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; TISSUE SECTION; TUMOR VASCULARIZATION; VULVA; VULVA CARCINOMA;

EID: 0037405443     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-8258(03)00055-6     Document Type: Article

References (41)

1. Folkman J. What is the evidence that tumors are angiogenesis dependant? J Natl Cancer Inst. 82:1990;4-6.
2. Folkman J., Shing Y. Angiogenesis. J Biol Chem. 267:1992;10931-10934.
3. Graham C.H., Rivers J., Kerbel R.S., Stankiewicz K.S., White W.L. Extent of vascularisation as a prognostic indicator in thin (<0.76mm) malignant melanomas. Am J Pathol. 145:1994;510-514.
4. Kato T., Kameoka S., Kimura T., Soga N., Abe Y., Nishikawa T., Kobayashi M. Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer. Breast Cancer Res Treat. 70:2001;65-74.
5. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma . N Engl J Med. 324:1991;1-8.
6. Macchiarini P., Fontanini G., Dulmet E., de Montpreville V., Chapelier A.R., Cerrina J., et al. Angiogenesis an indicator of metastases in non-small lung cancer invading the thoracic inlet . Ann Thorac Surg. 57:1994;1534-1539.
7. Weidner N., Carroll P.R., Flax J., Blumenfeld W., Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostatic carcinoma. Am J Pathol. 143:1993;401-409.
8. Obermair A., Kohlberger P., Bancher-Todesca D., Tempfer C., Sliutz G., Leodolter S., et al. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on the prognosis in vulval cancer. Gynecol Oncol. 63:1996;204-209.
9. MacLean A.B. Precursors of vulval cancers. Curr Obstet Gynaecol. 3:1993;149-156.
10. report of the Committee on Terminology. Am J Obstet Gynecol. 100:1989;769-770.
11. MacLean A.B., Roberts D.T., Reid W.M.N. Review of 1000 women seen at two specially designated vulval clinics. Curr Obstet Gynaecol. 8:1998;159-162.
12. Carlson J.A., Ambros R., Malfetano J., Ross J., Grabowski R., Lamb P., et al. Vulvar lichen sclerosus and squamous cell carcinoma a cohort, case control and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia . Hum Pathol. 29:1998;932-948.
13. Jones R.W., Rowan D.M. Vulval intraepithelial neoplasia. III. A clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Obstet Gynecol. 84:1994;741-745.
14. Herod JJO Shafi M.I., Rollason T.P., Jordan J.A., Luesley D.M. Vulval intraepithelial neoplasia long term follow-up of treated and untreated women . Br J Obstet Gynaecol. 103:1996;446-452.
15. Iversen T., Tretli S. Intraepithelial and invasive squamous cell neoplasia of the vulva trends in incidence, recurrence and survival rate in Norway . Obstet Gynecol. 91:1998;969-972.
16. Bancher-Todesca D., Obermair A., Bilgi S., Kohlberger P., Kainz C., Breitenecker G., et al. Angiogenesis in vulvar intraepithelial neoplasia. Gynecol Oncol. 64:1997;496-500.
17. MacLean A.B., Reid W.M., Rolfe K.J., Gammell S.J., Pugh H.E.J., Gatter K.C., et al. Role of angiogenesis in benign, premalignant and malignant vulvar lesions. J Reprod Med. 45:2000;609-612.
18. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat. 36:1995;169-180.
19. Miettinen M., Lindenmayer A.E., Chaubal A. Endothelial cell marker CD31, CD34, and BNH antibody to H- and Y- antigens evaluation of their sensitivity and specificity in the diagnosis of vascular tumors and comparison with von Willebrand factor . Mod Pathol. 7:1994;82-90.
20. Folkman J., Watson K., Ingber D., Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature. 339:1989;58-61.
21. Konerding M.A., Fait E., Gaumann A. 3D microvascular architecture of precancerous lesions and invasive carcinomas of the colon. Br J Cancer. 84:2001;1354-1362.
22. Bosari S., Lee A.K.C., DeLellis R.A., Wiley B.D., Heatley G.J., Silverman M.L. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol. 23:1992;755-761.
23. Guidi A.J., Fisher L., Harris J.R., Schnitt S.J. Microvessel density and distribution of ductal carcinoma in-situ of the breast. J Natl Cancer Inst. 86:1995;614-619.
24. Smith-McCune K.K., Weidner N. Demonstration and characterisation of the angiogenic properties of cervical dysplasia. Cancer Res. 54:1994;800-804.
25. Dobbs S.P., Hewett P.W., Johnson I.R., Carmichael J., Murray J.C. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br J Cancer. 76:1997;1410-1415.
26. Abulafia O., Triest W., Sherer D.M., Hansen C.C., Ghezi F. Angiogenesis in endometrial hyperplasia and stage 1 endometrial carcinoma. Obstet Gynecol. 86:1995;479-485.
27. Furusato M., Wakui S., Sasaki H., Ito K., Ushigome S. Tumor angiogenesis in latent prostatic carcinoma. Br J Cancer. 70:1994;1244-1246.
28. Bossi P., Viale G., Lee A.K.C., Alfano R.M., Coggi G., Bossari S. Angiogenesis in colorectal tumors microvessel quantitation in adenomas and carcinomas with clinicopathological correlations . Cancer Res. 55:1995;5049-5053.
29. Vilmer C., Cavelier-Balloy B., Nogues C., Trassard M., le Daussal V. Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with associated carcinoma a study of 67 cases . Eur J Gynaec Oncol. 19:1998;25-31.
30. Koller O. Colpophotography as an aid in the study of vulvar lesions. Acta Obstet Gynecol Scand. 45:1966;88-101.
31. Sillman F., Boyce J., Fruchter R. The significance of atypical vessels and neovascularization in cervical neoplasia. Am J Obstet Gynecol. 139:1981;154-159.
32. Doldi N., Origoni M., Bassan M., Ferrari D., Rossi M., Ferrari A. Vascular endothelial growth factor expression in human vulvar neoplastic and nonneoplastic tissues . J Reprod Med. 41:1996;844-848.
33. Tan S.-H., Derrick E., McKee P.H., Hobbs C., Ridley M., Neill S. Altered p53 expression and epidermal cell proliferation is seen in vulval lichen sclerosus. J Cutan Pathol. 21:1994;316-323.
34. Neill S.M., Staughton R.C.D., Lane E.B., Leigh I.M. The cytokeratin profile of normal vulval epithelium and vulval lichen sclerosus. Br J Dermatol. 123:(Suppl. 37):1990;62.
35. Pinto A.P., Lin M.-C., Sheets E.E., Muto M.G., Sun D., Crum C.P. Allelic imbalance in lichen sclerosus, hyperplasia and intraepithelial neoplasia of the vulva. Gynecol Oncol. 77:2000;171-176.
36. Rolfe K.J., Eva L.J., MacLean A.B., Crow J.C., Perret C.W., Reid W.M.N. Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus. Int J Gynecol Cancer. 11:2001;113-118.
37. Wang J.M., Kumar S., Pye D., van Agthoven A.J., Krupinski J., Hunter R.D. A monoclonal antibody detects heterogeneity in vascular endothelium of tumors and normal tissue. Int J Cancer. 54:1993;363-370.
38. Wang J.M., Kumar S., Pye D., Haboubi N., Al-Nakib L. Breast carcinoma comparative study of tumour vasculature using two endothelial-cell markers . J Natl Cancer Inst. 86:1994;386-388.
39. Jain R.K. Determinants of tumor blood flow a review . Cancer Res. 48:1988;2641-2658.
40. Gourley M., Williamson J.S. Angiogenesis new targets for the development of anticancer chemotherapies . Curr Pharm Des. 6:2000;417-439.
41. Logothetis C.J., Wu K.K., Finn L.D., Daliani D., Figg W., Ghaddar H., Gutterman J.U. Phase 1 trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer. Clin Cancer Res. 7:2001;1198-1203.